Business Context and Reporting Period
This Form 6-K filing is submitted by Mind Medicine (MindMed) Inc., a foreign private issuer, for the month of December 2021. The report was signed by CEO Robert Barrow on December 7, 2021. The filing serves to disclose specific corporate events rather than routine financial performance.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of corporate governance events and does not contain financial statements or operational metrics.
Material Changes
The primary material change disclosed in this filing is the change of independent registered public accounting firm. The filing includes:
- A notice dated December 6, 2021, regarding the auditor change.
- A letter from the former auditor dated December 6, 2021.
- A letter from the successor auditor dated December 6, 2021.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, or contingencies beyond the procedural disclosure of the auditor transition. No unusual items or non-recurring charges are detailed in the provided text.
Key Facts for Investor Verification
- Verify the reasons for the change in independent auditors by reviewing the attached letters (Exhibits 99.2 and 99.3).
- Confirm the identity of the successor auditor to assess their qualifications and independence.
- Note that this filing does not contain updated financial results; investors should refer to the most recent Form 20-F or 40-F for financial data.